投资工具 / 美股
Pfizer · PFE
数据仅供参考,不构成投资建议。
投资工具 / 美股
数据仅供参考,不构成投资建议。
| 季度 | 截止日 | 申报日 | 营收 | 营收同比 g | Δg | 推导方式 |
|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-27 | 2026-11-03 | $16.58B | −0.4% | −3.0pp | 3M |
| 2026Q2 | 2026-06-28 | 2026-08-04 | $15.03B | +2.6% | −2.8pp | 3M |
| 2026Q1 | 2026-03-29 | 2026-05-05 | $14.45B | +5.4% | +6.5pp | 3M |
| 2025Q4 | 2025-12-31 | 2026-11-03 | $17.56B | −1.2% | +4.8pp | FY-9M |
| 2025Q3 | 2025-09-28 | 2026-11-03 | $16.65B | −5.9% | −16.2pp | 3M |
| 2025Q2 | 2025-06-29 | 2026-08-04 | $14.65B | +10.3% | +18.1pp | 3M |
| 2025Q1 | 2025-03-30 | 2026-05-05 | $13.72B | −7.8% | −29.7pp | 3M |
| 2024Q4 | 2024-12-31 | 2026-02-26 | $17.76B | +21.9% | −9.3pp | FY-9M |
口径:单季同比;Δg = 本季 g − 上季 g;按财季映射日历季度;申报日可见。† 不连续点(上年同季营收 ≤0 或 Δg 幅度超过 50pp)。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 季度 | 截止日 | 毛利 | 销货成本 | 毛利率 | 环比 | 同比 | Δ² |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-27 | 无数据 | $4.03B | 75.7% | +293bp | +76bp | +220bp |
| 2026Q2 | 2026-06-28 | 无数据 | $4.09B | 72.8% | −267bp | −144bp | +237bp |
| 季度 | 截止日 | 合同负债 | CL g | RPO | RPO g | 账单额 | 账单额 g | RPO 覆盖 |
|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-27 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
| 季度 | 截止日 | OCF TTM | OCF g | CapEx TTM | CapEx g | FCF TTM | CapEx 密度 | SBC/FCF | SBC/Rev |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-27 | $14.17B | +8.4% | $2.39B | −11.6% | $11.79B | 3.8% | 9.4% | 1.7% |
| 2026Q2 | 2026-06-28 | $13.4B |
| 季度 | 截止日 | 存货 | 存货 g | 营收 g | 剪刀差 | DIO | DIO 同比 |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-27 | $10.02B | −12.6% | −0.4% | −12.2pp | 227.0 | −23.8 |
| 2026Q2 | 2026-06-28 | $9.95B | −14.8% | +2.6% | −17.4pp | 221.8 |
| 交易日 | 申报日 | 申报人 | 头衔 | 代码 | 股数 | 价格 | 金额 | 10b5-1 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | 2026-08-12 | BOURLA ALBERT |
口径:修正广度 =(近 30 日上调 − 下调)/(上调 + 下调),样本 < 3 不出;只展示衍生指标,不展示一致预期原值。 · 数据截至 2026-11-16 · 来源:Yahoo Finance / Nasdaq
未覆盖(期权覆盖为 S&P 500 期权持仓前 100 名每日、其余每周轮换)
暂无警报
口径:本股的警报事件历史(含基线);事件保留 90 天。
| 2026Q1 | 2026-03-29 | 无数据 | $3.55B | 75.4% | +548bp | −381bp | −705bp |
| 2025Q4 | 2025-12-31 | 无数据 | $5.27B | 70.0% | −498bp | +324bp | −144bp |
| 2025Q3 | 2025-09-28 | 无数据 | $4.17B | 74.9% | +73bp | +468bp | +562bp |
| 2025Q2 | 2025-06-29 | 无数据 | $3.78B | 74.2% | −504bp | −94bp | −291bp |
| 2025Q1 | 2025-03-30 | 无数据 | $2.85B | 79.3% | +1252bp | +197bp | −1668bp |
| 2024Q4 | 2024-12-31 | 无数据 | $5.91B | 66.7% | −353bp | +1865bp | −2033bp |
口径:GM = 毛利/营收;毛利缺失时用 营收−销货成本 推导;环比/同比为基点。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 2026Q2 |
| 2026-06-28 |
| 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 |
| 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 |
| 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
| 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
| 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 |
| 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 |
| 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
| 2026Q1 | 2026-03-29 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
| 2025Q4 | 2025-12-31 | $784M | −48.1% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | $17.42B | +0.9% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
| 2025Q3 | 2025-09-28 | $924M | −54.3% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | $16.46B | −4.3% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
| 2025Q2 | 2025-06-29 | $1.12B | −55.6% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | $14.76B | +10.9% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
| 2025Q1 | 2025-03-30 | $1.01B | −59.6% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | $13.22B | −10.0% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
| 2024Q4 | 2024-12-31 | $1.51B | −44.0% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 | $17.25B | +14.5% | 缺口径:RevenueRemainingPerformanceObligation 最后申报于 2023-10-01 |
缺口径:合同负债(ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31);RPO(RevenueRemainingPerformanceObligation 最后申报于 2023-10-01)
口径:g = 同比;账单额 = 营收 + Δ合同负债(同口径);RPO 覆盖 = RPO / TTM 营收。跨口径(总额/仅流动)不比较。 合同负债口径: — · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| −11.8% |
| $2.42B |
| −12.1% |
| $10.99B |
| 3.8% |
| 8.6% |
| 1.5% |
| 2026Q1 | 2026-03-29 | $11.98B | −14.3% | $2.5B | −9.7% | $9.48B | 4.0% | 9.5% | 1.4% |
| 2025Q4 | 2025-12-31 | $11.7B | −8.2% | $2.63B | −9.6% | $9.08B | 4.2% | 8.8% | 1.3% |
| 2025Q3 | 2025-09-28 | $13.08B | +16.1% | $2.7B | −11.0% | $10.38B | 4.3% | 7.2% | 1.2% |
| 2025Q2 | 2025-06-29 | $15.19B | +89.7% | $2.75B | −13.9% | $12.44B | 4.3% | 6.6% | 1.3% |
| 2025Q1 | 2025-03-30 | $13.99B | +63.1% | $2.77B | −20.2% | $11.22B | 4.4% | 7.4% | 1.3% |
| 2024Q4 | 2024-12-31 | $12.74B | +46.5% | $2.91B | −25.5% | $9.84B | 4.6% | 8.9% | 1.4% |
口径:TTM = 近四个离散单季之和;FCF = OCF − CapEx;CapEx 密度 = CapEx/营收 TTM;FCF≤0 时 SBC/FCF 不计算。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| −60.1 |
| 2026Q1 | 2026-03-29 | $10.67B | −1.7% | +5.4% | −7.1pp | 274.3 | −73.7 |
| 2025Q4 | 2025-12-31 | $10.65B | −1.8% | −1.2% | −0.7pp | 184.4 | +16.8 |
| 2025Q3 | 2025-09-28 | $11.47B | −2.2% | −5.9% | +3.8pp | 250.8 | +47.6 |
| 2025Q2 | 2025-06-29 | $11.67B | +1.9% | +10.3% | −8.4pp | 281.8 | −34.7 |
| 2025Q1 | 2025-03-30 | $10.85B | −0.4% | −7.8% | +7.5pp | 348.1 | +53.9 |
| 2024Q4 | 2024-12-31 | $10.85B | +6.5% | +21.9% | −15.4pp | 167.6 | +44.6 |
口径:剪刀差 = 存货同比 − 营收同比(pp,正值=存货增速快于营收);DIO = 存货/销货成本 × 91.25 天。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| Chairman & CEO |
| P |
| 38,000 |
| $26.34 |
| $1M |
| 2026-08-05 | 2026-08-06 | DAMICO JENNIFER B. | SVP & Controller | S | 3,278 | $25.40 | $83.26K |
| 2026-08-05 | 2026-08-05 | BLAYLOCK RONALD E | — | P | 39,231 | $25.46 | $998.82K |
| 2026-08-05 | 2026-08-05 | Buckley Mortimer J | — | P | 37,632 | $25.52 | $960.37K |
| 2026-06-09 | 2026-06-10 | DAMICO JENNIFER B. | SVP & Controller | S | 2,000 | $25.70 | $51.4K |
| 2025-03-04 | 2025-03-06 | DAMICO JENNIFER B. | SVP & Controller | S | 2,500 | $25.93 | $64.83K |
| 2025-02-13 | 2025-02-14 | BLAYLOCK RONALD E | — | P | 19,457 | $25.65 | $499.07K |
| 2024-10-30 | 2024-10-31 | Gottlieb Scott | — | P | 1,000 | $28.24 | $28.24K |
口径:Form 4/4A 公开市场买入(P)与卖出(S),申报人为董事或高管;汇总与集群为近 365 天,明细为最近 40 笔。 · 数据截至 2026-11-16 · 来源:SEC EDGAR Form 4
口径:SI 来自 FINRA(双周结算);SI% 分母 = SEC 封面总股本;借券费为 IBKR 报价(非全市场);卖空占比 = 当日卖空量/总成交量。 · 数据截至 SI 2026-10-30 · Reg SHO 2026-11-16 · 借券 2026-11-11 · 沿用上一版 · 来源:FINRA、IBKR、iBorrowDesk